Finance

Lists
Q2 2026 earnings • released • EPS beat +10.86%
See results
PEPG:NASDAQ
PepGen Inc
$2.99
+4.91%
(+0.14) 1D
$2.99
-0.00% (-0.000100)
After hours
Closed: Aug 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PEPG...
Open
$2.90
High
$3.04
Low
$2.75
Mkt. cap
207.09M
Avg. vol.
1.14M
Volume
1.53M
52-wk high
$7.80
52-wk low
$1.01
EPS
-$1.75
Beta
1.89
Shares outstanding
69.26M
No. of employees
59
Open
$2.90
High
$3.04
Low
$2.75
Mkt. cap
207.09M
Avg. vol.
1.14M
Volume
1.53M
52-wk high
$7.80
52-wk low
$1.01
EPS
-$1.75
Beta
1.89
Shares outstanding
69.26M
No. of employees
59
News stories
From web sources and news partners
About PepGen Inc
CEO-
Employees59
Founded2018
Headquarters-
SectorBiotechnology
Websitepepgen.com
Analyst ratings
Based on 5 analysts giving stock ratings to PEPG in the past 3 months
Buy
Buy
4
Hold
0
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PEPG in the last 3 months.
Highest
Current $2.99
$20.00 (+568.90%)
Average
$8.90 (+197.66%)
Lowest
$2.50 (-16.39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tazeen Ahmad
Bank of America Securities
Sell
Reiterated
$2.50
-16.4%
08/07/2026
Ananda Ghosh
H.C. Wainwright
Buy
Reiterated
$20.00
+568.9%
08/07/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
$11.00
+267.9%
08/06/2026
Debjit Chattopadhyay
Guggenheim
Buy
Reiterated
$7.00
+134.1%
06/08/2026
Laura Chico
Wedbush
Buy
Maintained
$4.00
+33.8%
05/13/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$12.00
+301.3%
04/04/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
$15.00
+401.7%
03/31/2026
Unknown Analyst
Wedbush
Buy
Maintained
$9.00
+201%
03/23/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.26 / -$0.29
+10.86%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13.42M
13.85M
13.00M
12.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.23M
5.85M
5.94M
6.42M
Operating expense
18.65M
19.70M
18.94M
18.94M
Total operating expenses
18.65M
19.70M
18.94M
18.94M
Operating income
-18.65M
-19.70M
-18.94M
-18.94M
Other non operating income
-6.00K
-5.00K
-56.00K
50.00K
EBT including unusual items
-18.03M
-18.29M
-17.75M
-17.80M
EBT excluding unusual items
-18.03M
-18.29M
-17.75M
-17.80M
Income tax expense
-
49.00K
15.00K
16.00K
Effective tax rate
-
-0.27%
-0.08%
-0.09%
Other operating expenses
-
-
-
-
Net income
-18.03M
-18.34M
-17.76M
-17.81M
Net profit margin
-
-
-
-
Earnings per share
-0.52
-0.27
-0.26
-0.26
Interest and investment income
634.00K
1.42M
1.25M
1.09M
Interest expense
-
-
-
-
Net interest expenses
634.00K
1.42M
1.25M
1.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.32M
-19.37M
-18.62M
-18.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps